Hims & Hers Health (HIMS)Director sold ~$368K
Patrick Harrison Carroll, Director at Hims & Hers Health, sold ~$368K of Hims & Hers Health shares.
- ~$368K
- Approx. value · 10K sh @ $36.71
- 170K
- Holds after · shares reported
- Traded
- Dec 17, 2025
- Filed
- Dec 18, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 16, 2025Insider · 1 personInsiders: 9 sales (~$11.0M)
- Oct 17, 2025InsiderCFO sold ~$662K of HIMS shares in the open market
- Oct 27, 2025InsiderOfficer sold ~$132K of HIMS shares in the open market
- Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 10, 2025InsiderOfficer sold ~$112K of HIMS shares in the open market
- Nov 17, 2025InsiderCFO sold ~$853K of HIMS shares in the open market
- Nov 24, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
- Dec 9, 2025InsiderDirector sold ~$98K of HIMS shares in the open market
- Dec 17, 2025 · this disclosureInsiderDirector sold ~$368K of HIMS shares in the open market
What came next
- Dec 17, 2025Insider · 3 peopleInsiders: 3 sales (~$1.1M)
- Dec 22, 2025InsiderCFO sold ~$825K of HIMS shares in the open market
- Jan 5, 2026InsiderCFO sold ~$306K of HIMS shares in the open market
- Jan 20, 2026InsiderCFO sold ~$275K of HIMS shares in the open market
- Feb 3, 2026InsiderCFO sold ~$139K of HIMS shares in the open market
- Feb 19, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Feb 23, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 27, 2026InsiderOfficer sold ~$71K of HIMS shares in the open market
- Mar 17, 2026Insider · 3 peopleInsiders: 3 sales (~$2.7M)
- Mar 20, 2026InsiderCFO sold ~$219K of HIMS shares in the open market
- Apr 6, 2026InsiderCFO sold ~$79K of HIMS shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Hims & Hers Health
For Hims & Hers Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.
Other recent filings by Patrick Harrison Carroll, Chief Medical Officer
- SEC Form 4 at Hims & Hers Health (HIMS)Jun 23, 2026
- SEC Form 4 at Hims & Hers Health (HIMS)Sep 19, 2025
- SEC Form 4 at Hims & Hers Health (HIMS)Aug 8, 2025
- SEC Form 4 at Hims & Hers Health (HIMS)Mar 18, 2025
- SEC Form 4 at Hims & Hers Health (HIMS)Nov 13, 2024
The full history of Patrick Harrison Carroll, Chief Medical Officer is on the profile page.
How this filing works
Other disclosures at Hims & Hers Health
- SEC Form 4Oct 2, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 4Sep 23, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 4Sep 17, 2026
Everything OQRO holds on this company is on its HIMS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
